Corient Private Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.5M Sell
25,718
-21,690
-46% -$7.38M 0.01% 673
2025
Q4
$18.8M Buy
47,408
+8,016
+20% +$3.55M 0.01% 582
2025
Q3
$18M Sell
39,392
-2,760
-7% -$1.12M 0.03% 407
2025
Q2
$13.7M Sell
42,152
-513
-1% -$142K 0.02% 457
2025
Q1
$11.5M Sell
42,665
-235,901
-85% -$60.6M 0.02% 493
2024
Q4
$65.5M Buy
278,566
+81
+0% +$21.3K 0.11% 183
2024
Q3
$76.6M Buy
278,485
+3,749
+1% +$976K 0.12% 174
2024
Q2
$66.8M Buy
274,736
+129
+0% +$20.4K 0.12% 180
2024
Q1
$41M Sell
274,607
-89
-0% -$14.8K 0.07% 259
2023
Q4
$52.6M Buy
274,696
+1,579
+0.6% +$269K 0.1% 213
2023
Q3
$48.4M Buy
273,117
+588
+0.2% +$112K 0.11% 194
2023
Q2
$51.8M Sell
272,529
-353
-0.1% -$70K 0.12% 177
2023
Q1
$54.7M Buy
272,882
+270,010
+9,401% +$56.8M 0.15% 153
2022
Q4
$683K Buy
+2,872
New +$613K ﹤0.01% 1044

Other funds holding ALNY